Obesity Linked to Increased Risk for Progression to T2D in Children
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 18, 2023 -- For children with prediabetes, factors associated with an increased risk for progression to type 2 diabetes (T2D) include obesity, according to a study published online Oct. 12 in the Journal of the Endocrine Society.
Natasha Belsky, from Vanderbilt University School of Medicine in Nashville, Tennessee, and colleagues conducted a retrospective chart review of a pediatric prediabetes clinic. Data were included for 552 patients; during 2.4 ± 1.5 years, 6.5 percent progressed to T2D.
The researchers found that T2D progressors had a higher body mass index, hemoglobin A1c (HbA1c), two-hour glucose, and C-peptide at the initial visit. No significant difference was seen in fasting glucose. Male sex, initial visit HbA1c, and two-hour glucose level were all predictive of T2D progression in a multivariable model (hazard ratios, 2.4, 1.3 per 0.1 percent, and 1.2 per 10-mg/dL increase). An increase in body mass index of 4.2 kg/m2 was seen for patients who progressed to T2D, while children consistently taking metformin took longer to progress.
"This is a real-world study that highlights ways to identify the children at highest risk for diabetes and possible strategies for diabetes prevention in children such as treatment with antidiabetes or antiobesity medications," coauthor Ashley H. Shoemaker, M.D., also from Vanderbilt University, said in a statement. "Our study found patients who were on metformin had lower blood sugar levels and were slower to progress to diabetes."
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
ENDO: Cardiovascular Events Occur Less Often With GLP1-RA, SGLT-2i for T2D, Liver Disease
FRIDAY, June 7, 2024 -- For adults with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), glucagon-like peptide 1 receptor agonists...
Overweight in Teens, Young Adults Tied to Cerebrovascular Disease in Women
THURSDAY, June 6, 2024 -- Being overweight in adolescence or early adulthood is associated with an increased risk for cerebrovascular disease among women, according to a study...
Study Looks at Links Between Cognition, Psychopathology, Weight in Preteens
WEDNESDAY, June 5, 2024 -- Lower cognition and greater psychopathology at baseline are associated with increased weight gain for children entering adolescence, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.